Anales de la RANM

235 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 ANEMIA DE FANCONI Y MANIFESTACIONES ENDOCRINAS Corredor Andrés B, et al. An RANM. 2026;143(02): 227 - 236 DECLARACIÓN DE TRANSPARENCIA Los autores/as de este artículo declaran no tener ningún tipo de conflicto de intereses respecto a lo expuesto en el presente trabajo. BIBLIOGRAFÍA 1. García-De-Teresa B, Rodríguez A, Frias S. Chromosome Instability in Fanconi Anemia: From Breaks to Phenotypic Consequences. doi:10.3390/genes11121528. 2. Fiesco-Roa MO, Giri N, McReynolds LJ, Best AF, Alter BP. Genotype-Phenotype Associa- tions in Fanconi Anemia: A Literature Re- view. Blood Rev 2019; 37 : 100589. 3. Stevens RF, Meyer S. Fanconi and Glanzmann: The men and their works. Br J Haematol 2002; 119 : 901–904. 4. Ramírez MJ, Pujol R, Minguillón J, Bogliolo M, Persico I, Cavero D et al. Prognostic sig- nificance of mutation type and chromosome fragility in Fanconi anemia. Am J Hematol 2024. doi:10.1002/AJH.27520. 5. Bogliolo M, Pujol R, Aza-Carmona M, Mu- ñoz-Subirana N, Rodriguez-Santiago B, Ca- sado JA et al. Optimised molecular genetic diagnostics of Fanconi anaemia by whole exo- me sequencing and functional studies. J Med Genet 2020; 57 : 258–268. 6. Association of complementation group and mutation type with clinical outcome in fan- coni anemia. European Fanconi Anemia Re- search Group - PubMed. https://pubmed. ncbi.nlm.nih.gov/11110674/ (accessed 27 Feb2024). 7. Garaycoechea JI, Patel KJ. Why does the bone marrow fail in Fanconi anemia? Blood 2014; 123 : 26–34. 8. Castella M, Pujol R, Callén E, Ramírez MJ, Casado JA, Talavera M et al. Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impact. J Med Genet 2011; 48 : 242–250. 9. Homan CC, Scott HS, Venugopal P. Another Fanconi anemia gene joins the club. J Clin In- vest 2025; 135 . doi:10.1172/JCI192382. 10. Kimble DC, Lach FP, Gregg SQ, Donovan FX, Flynn EK, Kamat A et al. A comprehensive ap- proach to identification of pathogenic FAN- CA variants in Fanconi anemia patients and their families. Hum Mutat 2018; 39 : 237–254. 11. Pilonetto D V., Pereira NF, Bonfim CMS, Ri- beiro LL, Bitencourt MA, Kerkhoven L et al. A strategy for molecular diagnostics of Fan- coni anemia in Brazilian patients. Mol Genet Genomic Med 2017; 5 : 360–372. 12. Bogliolo M, Pujol R, Aza-Carmona M, Muñoz- Subirana N, Rodriguez-Santiago B, Casado JA et al. Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies. J Med Genet 2020; 57 : 258–268. 13. Anemia Research Fund F. Pautas para el ma- nejo clínico de la anemia de Fanconi, Quinta edición 2020. . 14. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF et al. A 20-year pers- pective on the International Fanconi Anemia Registry (IFAR). Blood 2003; 101 : 1249–1256. 15. Garaycoechea JI, Patel KJ. Why does the bone marrow fail in Fanconi anemia? Blood 2014; 123 : 26–34. 16. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003; 101 : 822–826. 17. Altintas B, Giri N, McReynolds LJ, Best A, Alter BP. Genotype-phenotype and outcome associations in patients with Fanconi anemia: the National Cancer Institute cohort. Haema- tologica 2023; 108 : 69–82. 18. Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev 2010; 24 : 101–122. 19. Karempelis P, Greenlund L, Gruhl R, Dorri- ty J, Wagner J, Roby B. Etiologies of hearing loss in Fanconi Anemia. Int J Pediatr Otor- hinolaryngol 2022; 155 . doi:10.1016 /J.IJ - PORL.2022.111068. 20. Graf CM, Nichele S, Siviero RB, Loth G, Tren- nepohl JP, Zinher MT et al. Ocular Manifesta- tions in Patients with Fanconi Anemia: A Sin- gle-Center Experience Including 106 Patients. J Pediatr 2022; 242 : 228-234.e1. 21. Kroeger PT, Drummond BE, Miceli R, Mc- Kernan M, Gerlach GF, Marra AN et al. The zebrafish kidney mutant zeppelin reveals that brca2/fancd1 is essential for pronephros deve- lopment. Dev Biol 2017; 428 : 148–163. 22. Sathyanarayana V, Lee B, Wright NB, Santos R, Bonney D, Wynn R et al. Patterns and frequen- cy of renal abnormalities in Fanconi anaemia: implications for long-term management. Pe- diatr Nephrol 2018; 33 : 1547–1551. 23. Chapter 2. Diagnosis of Fanconi Anemia: Tes- ting and Genetic Counseling. . 24. Bourke G, Wilks D, Kinsey S, Feltbower RG, Giri N, Alter BP. The incidence and spectrum of congenital hand differences in patients with Fanconi anaemia: analysis of 48 patients. J Hand Surg Eur Vol 2022; 47 : 711–715. 25. Rose SR, Myers KC, Rutter MM, Mueller R, Khoury JC, Mehta PA et al. Endocrine phe- notype of children and adults with Fanconi anemia. Pediatr Blood Cancer 2012; 59 : 690– 696. 26. Barbus C, Rayannavar A, Miller BS, Jenkins MJ, Addo OY, Rayes A et al. Development of spe- cific growth charts for children with Fanconi anemia. Am J Med Genet A 2024. doi:10.1002/ AJMG.A.63554. 27. Petryk A, Shankar RK, Giri N, Hollenberg AN, Rutter MM, Nathan B et al. Endocrine disor- ders in Fanconi anemia: recommendations for screening and treatment. J Clin Endocrinol Me- tab 2015; 100 : 803–811. 28. Dietz AC, Mehta PA, Vlachos A, Savage SA, Bresters D, Tolar J et al. Current Knowled- ge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplanta-